NaturoMed Therapeutics, the parent company of Stay Wyld Organics, is a vertically integrated functional and medicinal mushroom company. NaturoMed Therapeutics is currently producing bulk functional mushroom powders at its state of the art facility in BC, Canada and selling functional mushroom products to the retail market throughout North America. The company is committed to improving global mental and physical health through the production and distribution of high-quality Canadian grown organic mushroom products. NaturoMed is excited to announce that construction is well underway for its Health Canada Controlled Substances Dealer’s License to produce Psilocybin. Estimated completion is Q4, 2022. NaturoMed plans to produce Psilocybin once it receives the license. NaturoMed’s lead scientist is currently working on new extraction processes to create medicinal IP.
Similar Posts
Psychedelic Business Spotlight: July 9, 2021
This week in psychedelic business news: It’s all about partnerships and acquisitions designed to advance psychedelic therapies for depression, suicidal ideation, pain, and more.
The Messy Job of a Psychedelic Integration Coach
Psychedelic therapy involves the processing of many complex emotions, and the psychedelic integration coach is here to help
CEO of Canadian Stock Exchange on Psychedelic Investments
Listening to Richard Carleton – the CEO of the Canadian…
Yep – Legal Ayahuasca Churches Are a Thing in Montreal
The ayahuasca church was granted an exemption on religious grounds and is one of six Canadian organizations allowed to utilize it.
Cathie Woods’ ARK Invest Conducting ‘Deep Dive’ Into Psychedelic Stocks
Cathie Wood and Ark Invest buying psychedelic stocks will be significant for the industry, as Wood holds a megaphone with which she communicates to retail growth investors.
Survey Shows American Psychologists Still Don’t Really Understand Psychedelics
Less than half of psychologists surveyed agreed that psychedelics showed promise in the treatment of serious mental health issues.